Lot certificates published
Plain, secure packaging

fragment of

TB-500 vs Thymosin beta-4

The Library's TB-500 record concerns an N-terminally acetylated seven-residue fragment, distinct from the 43-residue thymosin beta-4 parent. This identity relationship establishes neither a processing pathway nor the identity of commercial material.

Published: 2026-10-05Library record comparison: 2026-10-05

01

Identity side by side

Recorded molecular identities of TB-500 and Thymosin beta-4
Recorded fieldTB-500Thymosin beta-4
Canonical nameTB-500Timbetasin
AliasesN-acetyl-thymosin beta-4 (17-23)Thymosin b4; Tbeta4; TB4
Development codesnot recordednot recorded
CAS885340-08-977591-33-4
UNIIQHK6Z47GTG2D5MRE3SSY
PubChem CID6270766216132341
Molecular formulanot recordedC212H350N56O78S
Molecular weight (Da)not recorded4963.5
Sequence length (residues)743
Terminal modificationsN-terminal acetylation at Leu1; Free C-terminal carboxylN-terminal acetylation; Free C-terminal carboxyl
Structural modificationsnot recordednot recorded

TB-500: nomenclature notes

TB-500 is a product designation whose use does not uniquely specify a molecular structure. This dossier concerns the acetylated LKKTETQ referent identified in analytical literature. PubChem CID 62707662 and GSRS UNII QHK6Z47GTG, which lists CAS 885340-08-9, identify Ac-LKKTETQ-OH; these identifiers describe the defined fragment and do not establish the composition of another preparation labeled TB-500. It does not establish the identity or composition of a commercial preparation.

Thymosin beta-4: nomenclature notes

Timbetasin is the INN for thymosin beta-4. TB-500 is not this molecule. That name designates a distinct seven-residue fragment, carried separately in PubChem as CID 62707662 with a molecular mass of approximately 889 daltons, against 4963.5 daltons for the full-length peptide described here; the two records also carry different UNII identifiers. Material sold as TB-500 should be identified against the intended species rather than against this record. The PubChem synonym set for this record also includes a carbon-13-labelled internal standard used in mass spectrometry; that labelled compound has a different exact mass and must not be used as an identity reference for unlabelled material.

02

Recorded modification details

An aligned one-letter sequence is not recorded for this pair. The stored modification and sequence notes are shown below.

TB-500

Terminal modifications
N-terminal acetylation at Leu1; Free C-terminal carboxyl
Structural modifications
not recorded
Stored three-letter notation
Leu · Lys · Lys · Thr · Glu · Thr · Gln
Sequence notes
The residue sequence LKKTETQ corresponds to positions 17-23 of mature human thymosin beta-4 and positions 18-24 of UniProt P62328, whose initiator methionine is removed. The fragment's N-terminal acetyl modification is attached to leucine, rather than to the serine that begins the mature parent.

Thymosin beta-4

Terminal modifications
N-terminal acetylation; Free C-terminal carboxyl
Structural modifications
not recorded
Stored three-letter notation
Ser · Asp · Lys · Pro · Asp · Met · Ala · Glu · Ile · Glu · Lys · Phe · Asp · Lys · Ser · Lys · Leu · Lys · Lys · Thr · Glu · Thr · Gln · Glu · Lys · Asn · Pro · Leu · Pro · Ser · Lys · Glu · Thr · Ile · Glu · Gln · Glu · Lys · Gln · Ala · Gly · Glu · Ser
Sequence notes
Forty-three residues of the mature chain, numbered from Ser1; UniProt P62328 lists the same chain as positions 2-44 because its initiator methionine is removed. Ser1 is N-acetylated and Ser43 carries a free carboxyl, as encoded by PubChem CID 16132341; the one-letter string does not show the acetyl group. Positions 17-23, LKKTETQ, are the fragment described in the TB-500 record. Summing the forty-three residues, removing forty-two waters and adding the acetyl increment C2H2O gives C212H350N56O78S and 4963.51 Da, reproducing the recorded formula.

03

Recorded mechanisms

These lists show the links recorded in each monograph. An unlisted link does not establish its absence from the molecule’s biology.

Shared recorded links

not recorded

Recorded only for TB-500

not recorded

Recorded only for Thymosin beta-4

04

Recorded compound classes

Shared recorded links

not recorded

Recorded only for TB-500

Recorded only for Thymosin beta-4

05

References for the relationship

  1. Reference 1

    Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential.

    Esposito S, Deventer K, Goeman J, Van der Eycken J, Van Eenoo P

    Drug testing and analysis · 2012-09-07 · Journal Article

    current
  2. Reference 2

    Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry.

    Ho EN, Kwok WH, Lau MY, Wong AS, Wan TS, Lam KK, Schiff PJ, Stewart BD

    Journal of chromatography. A · 2012-09-23 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Esposito S et al. 2012Chemical, structural or analytical study; no biological model reported
Ho EN et al. 2012Study models reported: in vitro; animal (horse) · from the abstract

06

Read the full monographs